PrediSurge funding allows for technological advances.
Bremens Avocats is pleased to have supported investors LIFTT, Credit Agricole LHL Capital Innovation, and UI Investissement – Metropoles Innovations with their investment in PrediSurge.
PrediSurge, a French company, is committed to the development of a precision-medicine platform for cardiovascular interventions. They are working to improve the safety of endovascular interventions by providing numerical tools for physicians and Medtech firms.
This investment will accelerate PrediSurge’s growth, including their expansion into international markets. This investment will allow the company to increase their sales, allowing them to reach a wider audience of professionals and ultimately improve patient outcomes.
PrediSurge wants their technology to be available to the vast majority, so they have invested this money into their predictive software.
LIFTT S.p.A. Credit Agricole LHL Capital Innovation, UI Investissement – Metropoles Innovations are funds that support a wide range of technologies. Their main goal is to encourage the commercialisation process.
PrediSurge has achieved a 6.5 million Euro investment that will drastically propel their technology.
Bremens Avocats was part of the legal advisory team.